Florica Therapeutics develops exosome-based therapeutics to extend the life and prevent aging diseases.
Florica Therapeutics develops exosome-based therapeutics to extend the life and prevent aging diseases. The company was founded in 2019 and is headquartered in Livermore, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 6, 2021 | Grant | $275.67K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |